Literature DB >> 24792913

Macrophage-restricted interleukin-10 receptor deficiency, but not IL-10 deficiency, causes severe spontaneous colitis.

Ehud Zigmond1, Biana Bernshtein2, Gilgi Friedlander3, Catherine R Walker4, Simon Yona2, Ki-Wook Kim2, Ori Brenner5, Rita Krauthgamer2, Chen Varol6, Werner Müller4, Steffen Jung7.   

Abstract

Interleukin-10 (IL-10) is a pleiotropic anti-inflammatory cytokine produced and sensed by most hematopoietic cells. Genome-wide association studies and experimental animal models point at a central role of the IL-10 axis in inflammatory bowel diseases. Here we investigated the importance of intestinal macrophage production of IL-10 and their IL-10 exposure, as well as the existence of an IL-10-based autocrine regulatory loop in the gut. Specifically, we generated mice harboring IL-10 or IL-10 receptor (IL-10Rα) mutations in intestinal lamina propria-resident chemokine receptor CX3CR1-expressing macrophages. We found macrophage-derived IL-10 dispensable for gut homeostasis and maintenance of colonic T regulatory cells. In contrast, loss of IL-10 receptor expression impaired the critical conditioning of these monocyte-derived macrophages and resulted in spontaneous development of severe colitis. Collectively, our results highlight IL-10 as a critical homeostatic macrophage-conditioning agent in the colon and define intestinal CX3CR1(hi) macrophages as a decisive factor that determines gut health or inflammation.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24792913     DOI: 10.1016/j.immuni.2014.03.012

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  214 in total

Review 1.  The role of the local environment and epigenetics in shaping macrophage identity and their effect on tissue homeostasis.

Authors:  Ido Amit; Deborah R Winter; Steffen Jung
Journal:  Nat Immunol       Date:  2016-01       Impact factor: 25.606

Review 2.  ALOX15 as a suppressor of inflammation and cancer: Lost in the link.

Authors:  Rui Tian; Xiangsheng Zuo; Jonathan Jaoude; Fei Mao; Jennifer Colby; Imad Shureiqi
Journal:  Prostaglandins Other Lipid Mediat       Date:  2017-01-13       Impact factor: 3.072

Review 3.  The Treatment of Inflammatory Bowel Disease in Patients with Selected Primary Immunodeficiencies.

Authors:  Dror S Shouval; Matthew Kowalik; Scott B Snapper
Journal:  J Clin Immunol       Date:  2018-06-29       Impact factor: 8.317

4.  Regulating repair: regulatory T cells in myocardial infarction.

Authors:  Matthias Nahrendorf; Filip K Swirski
Journal:  Circ Res       Date:  2014-06-20       Impact factor: 17.367

5.  Eomesodermin promotes the development of type 1 regulatory T (TR1) cells.

Authors:  Ping Zhang; Jason S Lee; Kate H Gartlan; Iona S Schuster; Iain Comerford; Antiopi Varelias; Md Ashik Ullah; Slavica Vuckovic; Motoko Koyama; Rachel D Kuns; Kelly R Locke; Kirrilee J Beckett; Stuart D Olver; Luke D Samson; Marcela Montes de Oca; Fabian de Labastida Rivera; Andrew D Clouston; Gabrielle T Belz; Bruce R Blazar; Kelli P MacDonald; Shaun R McColl; Ranjeny Thomas; Christian R Engwerda; Mariapia A Degli-Esposti; Axel Kallies; Siok-Keen Tey; Geoffrey R Hill
Journal:  Sci Immunol       Date:  2017-04-07

Review 6.  Intestinal Antigen-Presenting Cells: Key Regulators of Immune Homeostasis and Inflammation.

Authors:  Kyle L Flannigan; Duke Geem; Akihito Harusato; Timothy L Denning
Journal:  Am J Pathol       Date:  2015-05-11       Impact factor: 4.307

7.  Oral IL-10 suppresses colon carcinogenesis via elimination of pathogenicCD4+ T-cells and induction of antitumor CD8+ T-cell activity.

Authors:  Tao Gu; Magdia De Jesus; Heather C Gallagher; Thomas P Burris; Nejat K Egilmez
Journal:  Oncoimmunology       Date:  2017-04-20       Impact factor: 8.110

8.  Anti-inflammatory effect of IL-10 mediated by metabolic reprogramming of macrophages.

Authors:  W K Eddie Ip; Namiko Hoshi; Dror S Shouval; Scott Snapper; Ruslan Medzhitov
Journal:  Science       Date:  2017-05-05       Impact factor: 47.728

Review 9.  Genetically engineered mouse models for studying inflammatory bowel disease.

Authors:  Atsushi Mizoguchi; Takahito Takeuchi; Hidetomo Himuro; Toshiyuki Okada; Emiko Mizoguchi
Journal:  J Pathol       Date:  2015-11-14       Impact factor: 7.996

10.  Interleukin 1β Mediates Intestinal Inflammation in Mice and Patients With Interleukin 10 Receptor Deficiency.

Authors:  Dror S Shouval; Amlan Biswas; Yu Hui Kang; Alexandra E Griffith; Liza Konnikova; Ivan D Mascanfroni; Naresh S Redhu; Sandra M Frei; Michael Field; Andria L Doty; Jeffrey D Goldsmith; Atul K Bhan; Anthony Loizides; Batia Weiss; Baruch Yerushalmi; Tadahiro Yanagi; Xiuli Lui; Francisco J Quintana; Aleixo M Muise; Christoph Klein; Bruce H Horwitz; Sarah C Glover; Athos Bousvaros; Scott B Snapper
Journal:  Gastroenterology       Date:  2016-09-28       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.